LISATA THERAPEUTICS, INC. — Director's Dealing 2011

Aug 31, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-08-31

Reporting Person: Smith Robin L (Director, Chairman of Board and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-08-31	Common Stock, $0.001 par value	A	11637	$0.73	Acquired	1037849	Direct

Footnotes

F1: On July 22, 2011, the Compensation Committee of the Issuer's Board of Directors approved an arrangement whereby the Reporting Person shall receive, at her option, her net salary for the pay period ending July 31, 2011 through the pay period ending October 31, 2011 through the issuance to her by the Issuer of shares of the Issuer's common stock at the then-market price, under and subject to the terms and conditions of the Issuer's 2009 Equity Compensation Plan (the "2009 Plan").